Zai Lab (ZLAB) Short-term Investments (2018 - 2026)
Zai Lab (ZLAB) posted Short-term Investments of $100.0 million for Q1 2026, little changed sequentially from $100.0 million in Q4 2025, and little changed YoY from $100.0 million in Q1 2025.
Zai Lab (ZLAB) Short-term Investments (2018 - 2026) Analysis & Trends
Zai Lab has reported Short-term Investments for 9 years, with the latest figure at $100.0 million in Q1 2026.
- Quarterly Short-term Investments changed 0.0% year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $100.0 million, down 69.7% from the prior year.
- Short-term Investments was little changed at $100.0 million in Q1 2026 per ZLAB's latest filing, from $100.0 million in the prior quarter.
- Over five years, Short-term Investments peaked at $575.3 million in Q2 2022 and troughed at $15.5 million in Q2 2023.
- A 5-year average of $152.3 million and a median of $100.0 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 97.31% in 2023, then soared 1924.54% in 2024.
- Over 5 years, Short-term Investments stood at $575.3 million in 2022, then sank by 97.17% to $16.3 million in 2023, then jumped by 1924.54% to $330.0 million in 2024, then tumbled by 69.7% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $100.0 million, $100.0 million, and $100.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 100.00 Mn |
| Sep 30, 2025 | 100.00 Mn |
| Jun 30, 2025 | 100.11 Mn |
| Mar 31, 2025 | 100.00 Mn |
| Dec 31, 2024 | 330.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 16.30 Mn |
| Sep 30, 2023 | 31.60 Mn |
| Jun 30, 2023 | 15.50 Mn |
| Mar 31, 2023 | 50.55 Mn |
| Jun 30, 2022 | 575.27 Mn |
| Mar 31, 2022 | 465.27 Mn |
| Dec 31, 2021 | 445.00 Mn |
| Sep 30, 2021 | 170.00 Mn |
| Dec 31, 2020 | 744.68 Mn |
| Jun 30, 2020 | 205.00 Mn |